Schroeder Blake 4
4 · AXIM BIOTECHNOLOGIES, INC. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Schroeder Blake
Director
Transactions
- Other
Convertible Note (Convertible into Common Stock)
2022-02-10$25000.00/sh+25,000$625,000,000→ 307,692 totalExercise: $0.08From: 2022-02-10Exp: 2032-02-10→ Common Stock (307,692 underlying)
Footnotes (1)
- [F1]This Note bears interest at a rate of 3% per annum. At the election of the Reporting Person, all principal and accrued interest under the Note may be converted into the Issuer's common stock at a converstion price equal to the lesser of $0.08125 or 70% of the average of the two lowest closing prices of the Issuer's common stock in the ten (10) days prior to the date of conversion.